<?xml version="1.0" encoding="utf-8" ?>
<INTERACTIONS>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>31-AMINOGLUTETHIMIDE.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name="AMINOGLUTETHIMIDE" rxcui="677">
<ATC code="L02BG01" />
</DRUG>
</DRUG1>
<DRUG2>
<CLASS name="VITAMIN K ANTAGONISTS" code="B01AA-001" /></DRUG2>
<DESCRIPTION>Described for warfarin and acenocoumarol. 

Decrease of the effect of the vitamin K antagonist, due to increase of its hepatic metabolism by the aminoglutethimide

.</DESCRIPTION>
<SEVERITY>Precaution for use</SEVERITY>
<COMMENT>More frequent testing of the INR. Possible adjustment of the dosage of the Vitamin K antagonist during the treatment with aminoglutethimide and two weeks after it is stopped. </COMMENT>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>31-AMINOGLUTETHIMIDE.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name="AMINOGLUTETHIMIDE" rxcui="677">
<ATC code="L02BG01" />
</DRUG>
</DRUG1>
<DRUG2>
<DRUG name="DEXAMETHASONE" rxcui="3264">
<ATC code="A01AC02" />
<ATC code="C05AA09" />
<ATC code="D07AB19" />
<ATC code="D07XB05" />
<ATC code="D10AA03" />
<ATC code="H02AB02" />
<ATC code="R01AD03" />
<ATC code="S01BA01" />
<ATC code="S01CB01" />
<ATC code="S02BA06" />
<ATC code="S03BA01" />
<ATC code="D07CB04" />
<ATC code="S01CA01" />
<ATC code="S02CA06" />
<ATC code="S03CA01" />
<ATC code="R01AD53" />
</DRUG>
</DRUG2>
<DESCRIPTION>Decrease of the effectiveness of the dexamethasone, due to increase of its hepatic metabolism

</DESCRIPTION>
<SEVERITY>Precaution for use</SEVERITY>
<COMMENT>Adjustment of the dosage of the dexamethasone. </COMMENT>
</INTERACTION>
</INTERACTIONS>
